Elevated IL-1α expression has been associated with poor prognosis [4,5], and clinical studies by León et al. [6] further demonstrated that high expression of IL-1α in cancer cells correlates with an increased risk of distant metastasis in patients with head and neck cancers [4,5,6]. Here, IL1A is linked to head and neck cancer.